SCHEMBL2184686

SCHEMBL2184686

O=C1C(=Cc2cccc(O)c2)SC(=S)N1c1ccc(Cl)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPD1 P10809 1/20 0.62
HSPE1 P61604 1/20 0.62
MAPT P10636 5/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
ATM Q13315 1/20 0.58
DUSP22 Q9NRW4 7/20 0.57
TDP1 Q9NUW8 2/20 0.57
MAPK1 P28482 1/20 0.57
CFTR P13569 2/20 0.55
DUSP3 P51452 2/20 0.55
POLB P06746 2/20 0.54
THRB P10828 1/20 0.54
RECQL P46063 1/20 0.54
HSD17B3 P37058 1/20 0.53
S1PR1 P21453 1/20 0.53
S1PR3 Q99500 1/20 0.53
PTPN7 P35236 1/20 0.52
PTPN12 Q05209 1/20 0.52
PTPN22 Q9Y2R2 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2184682 1.00 HSPD1 (0.62) HSPD1HSPE1MAPTMEN1KMT2A
SCHEMBL13236159 0.88 MAPT (0.65) HSPD1HSPE1MAPTMEN1KMT2A
SCHEMBL2838465 0.81 PTPN2 (0.66) HSPD1HSPE1MAPTMEN1KMT2A
SCHEMBL2838460 0.81 PTPN2 (0.66) HSPD1HSPE1MAPTMEN1KMT2A
SCHEMBL2838462 0.81 PTPN2 (0.66) HSPD1HSPE1MAPTMEN1KMT2A
SCHEMBL14788063 0.79 HSPD1 (0.76) HSPD1HSPE1MAPTMEN1KMT2A
SCHEMBL13236134 0.79 HSPD1 (0.59) HSPD1HSPE1MAPTMEN1KMT2A
SCHEMBL20005793 0.79 MEN1 (0.68) HSPD1HSPE1MAPTMEN1KMT2A
SCHEMBL18103076 0.79 MEN1 (0.68) HSPD1HSPE1MAPTMEN1KMT2A
SCHEMBL19773079 0.77 CISD1 (0.69) MAPTMEN1KMT2AATMMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9949980-B2 Drugs to prevent HPV infection WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2018-04-24 US disclosed
US-20150297602-A1 DRUGS TO PREVENT HPV INFECTION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-10-22 US disclosed
US-9066951-B2 Drugs to treat HPV infection WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2015-06-30 US disclosed
US-20110165220-A1 DRUGS TO PREVENT HPV INFECTION WISCONSIN ALUMNI RESEARCH FOUNDATION 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165220-A1 DRUGS TO PREVENT HPV INFECTION VHL, PHF13, CDKN1A HSPD1 3475/4885HSPE1 3159/4885MAPT 4500/4885
US-20150297602-A1 DRUGS TO PREVENT HPV INFECTION VHL, PHF13, CDKN1A HSPD1 3475/4885HSPE1 3159/4885MAPT 4500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.